6-甲基腺嘌呤RNA甲基化与眼科疾病的研究进展

Advances in N6-methyladenosine RNA methylation and ophthalmic diseases

  • 摘要: 6-甲基腺嘌呤(m6A)是指腺嘌呤核苷第6个氮原子位置发生甲基化, 是信使RNA(mRNA)和长链非编码RNA(LncRNA)中最常见的一种转录后修饰。m6A RNA甲基化在各种生物过程如组织发育、干细胞自我更新和分化、热休克、DNA损伤反应和母源至受精卵基因表达过渡阶段中发挥关键作用。m6A是真核细胞中一个重要的转录后mRNA调节剂,在各种疾病中也发挥着至关重要的作用。甲基化的RNA与各种类型的蛋白质相互作用,能够影响RNA生物学过程的翻译、降解、运输、稳定性和剪接等。m6A RNA甲基化在糖尿病视网膜病变、年龄相关性黄斑变性等常见眼部疾病中发挥着重要作用,其参与了氧化应激过程中抗氧化酶的调控和活性氧的清除。本文综述m6A RNA甲基化在眼部疾病中的潜在发病机制,为探索眼部疾病的发病机制提供新思路。

     

    Abstract: N6-methyladenosine (m6A) refers to the methylation modification at the sixth nitrogen atom position of adenine nucleoside, and is the most common post-transcriptional modification in messenger RNA (mRNA) and long non-coding RNA (LncRNA). M6A modification is involved in various biological processes such as tissue development, stem cell self-renewal and differentiation, heat shock, DNA damage response, and transition of gene expression from maternal to zygotic transition period. M6A is an important post-transcriptional mRNA regulator in eukaryotic cells, and also plays a vital role in various diseases. M6A modifications in RNA interact with various types of proteins and influence several aspects of RNA biological processes, such as translation, degradation, transport, stability, and splicing. m6A RNA methylation plays an important role in common eye diseases suchas diabetic retinopathy and age-related macular degeneration and is involved in the regulation of antioxidant enzymes and scavenging of reactive oxygen species during oxidative stress.

     

/

返回文章
返回